Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Alfa Laval on its takeover bid for Neles
Mandate

Vinge advises Alfa Laval on its takeover bid for Neles

July 13, 2020 Capital Markets and Public M&A Banking and Finance Corporate Tax

Alfa Laval AB (publ) has announced a recommended public cash offer to the shareholders of Neles Corporation.

The offer values all shares in Neles at approximately EUR 1.727 billion.

The Vinge team includes Erik Sjöman, Linnéa Sellström, Henrik Ossborn, Fabian Ekeblad, Fredrik Christiansson, Mattias Schömer and Maria Schultzberg.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026